|
Save Search
|
 |
|
|
|
Viewing 1-20 of 728769 Medline results for thisweek.asp;53
|
ER storage diseases: a role for ERGIC-53 in controlling the formation and shape of Russell bodies.
L Mattioli, T Anelli, C Fagioli, C Tacchetti, R Sitia, and C Valetti
J. Cell Sci.,
Jun 2006;
119:
2532-41.
Journal article
Abstract
|
Full text
|
Tumor protein 53-induced nuclear protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumor development.
M Gironella, M Seux, MJ Xie, C Cano, R Tomasini, J Gommeaux, S Garcia, J Nowak, ML Yeung, KT Jeang, A Chaix, L Fazli, Y Motoo, Q Wang, P Rocchi, A Russo, M Gleave, JC Dagorn, JL Iovanna, A Carrier, MJ Pebusque, and NJ Dusetti
PNAS,
Oct 2007;
104:
16170-5.
Journal article
Abstract
|
Full text
|
Safety profile of thalidomide after 53 weeks of oral administration in beagle dogs.
SK Teo, MG Evans, MJ Brockman, J Ehrhart, JM Morgan, DI Stirling, and SD Thomas
Toxicol. Sci.,
Jan 2001;
59:
160-8.
Journal article
Abstract
|
Full text
|
53Mn-53Cr dating of fayalite formation in the CV3 chondrite Mokoia: evidence for asteroidal alteration.
ID Hutcheon, AN Krot, K Keil, DL Phinney, and ER Scott
Science,
Dec 1998;
282:
1865-7.
Journal article
Abstract
|
Full text
|
unc-53 controls longitudinal migration in C. elegans.
E Stringham, N Pujol, J Vandekerckhove, and T Bogaert
Development,
Jul 2002;
129:
3367-79.
Journal article
Abstract
|
Full text
|
The sugar-binding ability of ERGIC-53 is enhanced by its interaction with MCFD2.
N Kawasaki, Y Ichikawa, I Matsuo, K Totani, N Matsumoto, Y Ito, and K Yamamoto
Blood,
Feb 2008;
111:
1972-9.
Journal article
Abstract
|
Full text
|
Regulation of ERGIC-53 gene transcription in response to endoplasmic reticulum stress.
M Renna, MG Caporaso, S Bonatti, RJ Kaufman, and P Remondelli
J. Biol. Chem.,
Aug 2007;
282:
22499-512.
Journal article
Abstract
|
Full text
|
Attenuation markers of a candidate dengue type 2 vaccine virus, strain 16681 (PDK-53), are defined by mutations in the 5' noncoding region and nonstructural proteins 1 and 3.
S Butrapet, CY Huang, DJ Pierro, N Bhamarapravati, DJ Gubler, and RM Kinney
J. Virol.,
Apr 2000;
74:
3011-9.
Journal article
Abstract
|
Full text
|
Targeting of protein ERGIC-53 to the ER/ERGIC/cis-Golgi recycling pathway.
C Itin, R Schindler, and HP Hauri
J. Cell Biol.,
Oct 1995;
131:
57-67.
Journal article
Abstract
|
The cell migration molecule UNC-53/NAV2 is linked to the ARP2/3 complex by ABI-1.
KL Schmidt, N Marcus-Gueret, A Adeleye, J Webber, D Baillie, and EG Stringham
Development,
Feb 2009;
136:
563-74.
Journal article
Abstract
|
Full text
|
p-53 gene mutations as a predictive marker in a population of advanced breast cancer patients randomly treated with doxorubicin or docetaxel in the context of a phase III clinical trial.
A Di Leo, M Tanner, C Desmedt, M Paesmans, F Cardoso, V Durbecq, S Chan, T Perren, M Aapro, C Sotiriou, MJ Piccart, D Larsimont, J Isola, and TAX 303 translational study team
Ann. Onc.,
Jun 2007;
18:
997-1003.
Clinical trial, phase iii
Abstract
|
Full text
|
Heat shock induces preferential translation of ERGIC-53 and affects its recycling pathway.
C Spatuzza, M Renna, R Faraonio, G Cardinali, G Martire, S Bonatti, and P Remondelli
J. Biol. Chem.,
Oct 2004;
279:
42535-44.
Journal article
Abstract
|
Full text
|
Antitumor activity of a novel podophyllotoxin derivative (TOP-53) against lung cancer and lung metastatic cancer.
T Utsugi, J Shibata, Y Sugimoto, K Aoyagi, K Wierzba, T Kobunai, T Terada, T Oh-hara, T Tsuruo, and Y Yamada
Cancer Res.,
Jun 1996;
56:
2809-14.
Journal article
Abstract
|
Identification of ERGIC-53 as an intracellular transport receptor of alpha1-antitrypsin.
B Nyfeler, V Reiterer, MW Wendeler, E Stefan, B Zhang, SW Michnick, and HP Hauri
J. Cell Biol.,
Feb 2008;
180:
705-12.
Journal article
Abstract
|
Full text
|
Glu-53 of Bacillus cereus sphingomyelinase acts as an indispensable ligand of Mg2+ essential for catalytic activity.
T Obama, Y Kan, H Ikezawa, M Imagawa, and K Tsukamoto
J. Biochem.,
Mar 2003;
133:
279-86.
Journal article
Abstract
|
Full text
|
Mistargeting of the lectin ERGIC-53 to the endoplasmic reticulum of HeLa cells impairs the secretion of a lysosomal enzyme.
F Vollenweider, F Kappeler, C Itin, and HP Hauri
J. Cell Biol.,
Jul 1998;
142:
377-89.
Journal article
Abstract
|
Full text
|
The recycling of ERGIC-53 in the early secretory pathway. ERGIC-53 carries a cytosolic endoplasmic reticulum-exit determinant interacting with COPII.
F Kappeler, DR Klopfenstein, M Foguet, JP Paccaud, and HP Hauri
J. Biol. Chem.,
Dec 1997;
272:
31801-8.
Journal article
Abstract
|
Full text
|
Characterization and cloning of a 58/53-kDa substrate of the insulin receptor tyrosine kinase.
TC Yeh, W Ogawa, AG Danielsen, and RA Roth
J. Biol. Chem.,
Feb 1996;
271:
2921-8.
Journal article
Abstract
|
Full text
|
The cargo receptors Surf4, endoplasmic reticulum-Golgi intermediate compartment (ERGIC)-53, and p25 are required to maintain the architecture of ERGIC and Golgi.
S Mitrovic, H Ben-Tekaya, E Koegler, J Gruenberg, and HP Hauri
Mol Biol Cell,
May 2008;
19:
1976-90.
Journal article
Abstract
|
Species-specific antibody responses to the recombinant 53-kilodalton excretory and secretory proteins in mice infected with Trichinella spp.
I Nagano, Z Wu, and Y Takahashi
Clin. Vaccine Immunol.,
Mar 2008;
15:
468-73.
Journal article
Abstract
|
Full text
|
|
|
|
|
|
